Automated Cell Culture Market Research Report - Forecast till 2030

Automated Cell Culture Market Research Report Information By Type (Whole Lab Automation, Modular Automation), By Application (Diagnostics, Biopharmaceutical Production, Toxicity Testing, Drug Screening & Development, Tissue Engineering & Regenerative Medicine, And Stem Cell Research), By End Users (Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Cell Banks, And Research Institutes), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2030

ID: MRFR/LS/0283-CR | 148 Pages | Author: Rahul Gotadki | July 2020         

1 EXECUTIVE SUMMARY

1.1 OVERVIEW 17

1.1.1 MARKET SYNOPSIS 18

2 MARKET INTRODUCTION

2.1 SCOPE OF THE STUDY 19

2.2 RESEARCH OBJECTIVE 19

2.3 LIST OF ASSUMPTIONS 20

3 RESEARCH METHODOLOGY

3.1 OVERVIEW 21

3.2 DATA MINING 21

3.3 SECONDARY RESEARCH 22

3.4 PRIMARY RESEARCH 23

3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 23

3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 24

3.5 FORECASTING TECHNIQUES 24

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 25

3.6.1 BOTTOM-UP APPROACH 26

3.6.2 TOP-DOWN APPROACH 27

3.7 DATA TRIANGULATION 28

3.8 VALIDATION 28

4 MARKET DYNAMICS

4.1 OVERVIEW 29

4.2 DRIVERS 30

4.2.1 GROWING RESEARCH AND DEVELOPMENT INITIATIVES IN THE PHARMACEUTICAL INDUSTRY 30

4.2.2 RISE IN ADOPTION OF LIQUID HANDLING SYSTEMS 30

4.2.3 INCREASING PREVALENCE OF CANCER AND OTHER CHRONIC DISEASES 31

4.3 RESTRAINTS 32

4.3.1 HIGH MAINTAINANCE COST 32

4.4 OPPORTUNITIES 33

4.4.1 RISING FOCUS ON REGENERATIVE MEDICINE 33

5 MARKET FACTOR ANALYSIS

5.1 PORTER’S FIVE FORCES MODEL 34

5.1.1 BARGAINING POWER OF SUPPLIERS 35

5.1.2 BARGAINING POWER OF BUYERS 35

5.1.3 THREAT OF NEW ENTRANTS 35

5.1.4 THREAT OF SUBSTITUTES 35

5.1.5 INTENSITY OF RIVALRY 35

5.2 VALUE CHAIN ANALYSIS 36

5.2.1 R&D AND DESIGNING 37

5.2.2 MANUFACTURING 37

5.2.3 DISTRIBUTION & SALES 37

5.2.4 POST-SALES MONITORING 37

5.3 IMPACT OF COVID-19 ON THE GLOBAL AUTOMATED CELL CULTURE MARKET 38

5.3.1 OVERVIEW 38

5.3.2 IMPACT ON CLINICAL TRIALS 38

5.3.3 IMPACT OF LABORATORY DEVELOPED TESTS (LDT) TO DIAGNOSE COVID-19 39

5.3.4 IMPACT ON TEST VOLUME, REVENUE, AND STAFFING 39

6 GLOBAL AUTOMATED CELL CULTURE MARKET BY TYPE

6.1 OVERVIEW 42

6.2 MODULAR AUTOMATION 43

6.3 WHOLE LAB AUTOMATION 44

7 GLOBAL AUTOMATED CELL CULTURE MARKET BY PRODUCT

7.1 OVERVIEW 46

7.2 CONSUMABLES 47

7.3 VESSELS 49

8 GLOBAL AUTOMATED CELL CULTURE MARKET BY APPLICATION

8.1 OVERVIEW 51

8.2 BIOPHARMACEUTICAL PRODUCTION 52

8.3 TISSUE ENGINEERING & REGENERATIVE MEDICINE 53

8.4 DRUG SCREENING AND DEVELOPMENT 54

8.5 GENE THERAPY 55

8.6 STEM CELL RESEARCH 56

8.7 DIAGNOSTICS 57

8.8 TOXICITY TESTING 58

9 GLOBAL AUTOMATED CELL CULTURE MARKET BY END USER

9.1 OVERVIEW 60

9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 61

9.3 RESEARCH INSTITUTES 62

9.4 HOSPITALS AND DIAGNOSTIC LABORATORIES 63

9.5 CELL BANKS 64

10 GLOBAL AUTOMATED CELL CULTURE MARKET BY REGION

10.1 OVERVIEW 66

10.2 AMERICAS 67

10.2.1 NORTH AMERICA 74

10.2.1.1 US 80

10.2.1.2 CANADA 84

10.2.2 LATIN AMERICA 87

10.3 EUROPE 91

10.3.1 WESTERN EUROPE 98

10.3.1.1 GERMANY 103

10.3.1.2 FRANCE 107

10.3.1.3 UK 111

10.3.1.4 ITALY 115

10.3.1.5 SPAIN 119

10.3.1.6 REST OF WESTERN EUROPE 123

10.3.2 EASTERN EUROPE 127

10.4 ASIA-PACIFIC 132

10.4.1 JAPAN 138

10.4.2 CHINA 142

10.4.3 INDIA 146

10.4.4 AUSTRALIA 150

10.4.5 SOUTH KOREA 154

10.4.6 REST OF ASIA-PACIFIC 158

10.5 MIDDLE EAST & AFRICA 162

10.5.1 MIDDLE EAST. 168

10.5.2 AFRICA 172

11 COMPETITIVE LANDSCAPE

11.1 OVERVIEW 177

11.2 COMPETITIVE ANALYSIS 177

11.3 COMPETITIVE BENCHMARKING 178

11.4 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS 178

11.5 MAJOR GROWTH STRATEGY IN THE GLOBAL AUTOMATED CELL CULTURE MARKET 179

11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 179

11.6.1 PRODUCT APPROVALS 179

11.6.2 ACQUISITIONS 181

11.6.3 AGREEMENTS/COLLABORATIONS 181

11.7 FINANCIAL MATRIX 182

12 COMPANY PROFILES

12.1 TECAN TRADING AG 183

12.1.1 COMPANY OVERVIEW 183

12.1.2 FINANCIAL OVERVIEW 184

12.1.3 PRODUCTS/SERVICES OFFERED 185

12.1.4 KEY DEVELOPMENTS 185

12.1.5 SWOT ANALYSIS 186

12.1.6 KEY STRATEGIES 186

12.2 SIEMENS 187

12.2.1 COMPANY OVERVIEW 187

12.2.2 FINANCIAL OVERVIEW 187

12.2.3 PRODUCTS/SERVICES OFFERED 189

12.2.4 KEY DEVELOPMENTS 189

12.2.5 SWOT ANALYSIS 190

12.2.6 KEY STRATEGIES 190

12.3 HITACHI, LTD 191

12.3.1 COMPANY OVERVIEW 191

12.3.2 FINANCIAL OVERVIEW 191

12.3.3 PRODUCTS/SERVICES OFFERED 192

12.3.4 KEY DEVELOPMENTS 192

12.3.5 SWOT ANALYSIS 193

12.3.6 KEY STRATEGIES 193

12.4 THERMO FISHER SCIENTIFIC INC. 194

12.4.1 COMPANY OVERVIEW 194

12.4.2 FINANCIAL OVERVIEW 194

12.4.3 PRODUCTS/SERVICES OFFERED 196

12.4.4 KEY DEVELOPMENTS 197

12.4.5 SWOT ANALYSIS 197

12.4.6 KEY STRATEGIES 197

12.5 SARTORIUS AG 198

12.5.1 COMPANY OVERVIEW 198

12.5.2 FINANCIAL OVERVIEW 198

12.5.3 PRODUCTS/SERVICES OFFERED 199

12.5.4 KEY DEVELOPMENTS 199

12.5.5 SWOT ANALYSIS 200

12.5.6 KEY STRATEGIES 200

12.6 HAMILTON COMPANY 201

12.6.1 COMPANY OVERVIEW 201

12.6.2 FINANCIAL OVERVIEW 201

12.6.3 PRODUCTS/SERVICES OFFERED 201

12.6.4 KEY DEVELOPMENTS 201

12.6.5 SWOT ANALYSIS 202

12.6.6 KEY STRATEGIES 202

12.7 BECKMAN COULTER, INC. 203

12.7.1 COMPANY OVERVIEW 203

12.7.2 FINANCIAL OVERVIEW 203

12.7.3 PRODUCTS/SERVICES OFFERED 203

12.7.4 KEY DEVELOPMENTS 203

12.7.5 SWOT ANALYSIS 204

12.7.6 KEY STRATEGIES 204

12.8 F. HOFFMANN-LA ROCHE LTD 205

12.8.1 COMPANY OVERVIEW 205

12.8.2 FINANCIAL OVERVIEW 205

12.8.3 PRODUCTS/SERVICES OFFERED 207

12.8.4 KEY DEVELOPMENTS 207

12.8.5 SWOT ANALYSIS 207

12.8.6 KEY STRATEGIES 207

12.9 MERCK KGAA 208

12.9.1 COMPANY OVERVIEW 208

12.9.2 FINANCIAL OVERVIEW 208

12.9.3 PRODUCTS/SERVICES OFFERED 209

12.9.4 KEY DEVELOPMENTS 209

12.9.5 SWOT ANALYSIS 210

12.9.6 KEY STRATEGIES 210

12.10 BECTON, DICKINSON AND COMPANY 211

12.10.1 COMPANY OVERVIEW 211

12.10.2 FINANCIAL OVERVIEW 212

12.10.3 PRODUCTS/SERVICES OFFERED 213

12.10.4 KEY DEVELOPMENTS 213

12.10.5 SWOT ANALYSIS 214

12.10.6 KEY STRATEGIES 214

13 APPENDIX

13.1 REFERENCES 215

13.2 RELATED REPORTS 215

14 LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS 20

TABLE 2 GLOBAL AUTOMATED CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION) 42

TABLE 3 GLOBAL AUTOMATED CELL CULTURE MARKET, FOR MODULAR AUTOMATION, BY REGION, 2020–2027 (USD MILLION) 43

TABLE 4 GLOBAL AUTOMATED CELL CULTURE MARKET, FOR WHOLE LAB AUTOMATION, BY REGION, 2020–2027 (USD MILLION) 44

TABLE 5 GLOBAL AUTOMATED CELL CULTURE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 46

TABLE 6 GLOBAL AUTOMATED CELL CULTURE MARKET, FOR CONSUMABLES, BY REGION, 2020–2027 (USD MILLION) 47

TABLE 7 GLOBAL AUTOMATED CELL CULTURE MARKET, FOR CONSUMABLES, BY TYPE, 2020–2027 (USD MILLION) 47

TABLE 8 GLOBAL AUTOMATED CELL CULTURE MARKET, FOR VESSELS, BY REGION, 2020–2027 (USD MILLION) 48

TABLE 9 GLOBAL AUTOMATED CELL CULTURE MARKET, FOR VESSELS, BY TYPE, 2020–2027 (USD MILLION) 49

TABLE 10 GLOBAL AUTOMATED CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 51

TABLE 11 GLOBAL AUTOMATED CELL CULTURE MARKET, FOR BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2020–2027

(USD MILLION) 52

TABLE 12 GLOBAL AUTOMATED CELL CULTURE MARKET, FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION,

2020–2027 (USD MILLION) 53

TABLE 13 GLOBAL AUTOMATED CELL CULTURE MARKET, FOR DRUG SCREENING AND DEVELOPMENT, BY REGION,

2020–2027 (USD MILLION) 54

TABLE 14 GLOBAL AUTOMATED CELL CULTURE MARKET, FOR GENE THERAPY, BY REGION, 2020–2027 (USD MILLION) 55

TABLE 15 GLOBAL AUTOMATED CELL CULTURE MARKET, FOR STEM CELL RESEARCH, BY REGION, 2020–2027 (USD MILLION) 56

TABLE 16 GLOBAL AUTOMATED CELL CULTURE MARKET, FOR DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION) 57

TABLE 17 GLOBAL AUTOMATED CELL CULTURE MARKET, FOR TOXICITY TESTING, BY REGION, 2020–2027 (USD MILLION) 58

TABLE 18 GLOBAL AUTOMATED CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION) 60

TABLE 19 GLOBAL AUTOMATED CELL CULTURE MARKET, FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION,

2020–2027 (USD MILLION) 61

TABLE 20 GLOBAL AUTOMATED CELL CULTURE MARKET, FOR RESEARCH INSTITUTES, BY REGION, 2020–2027 (USD MILLION) 62

TABLE 21 GLOBAL AUTOMATED CELL CULTURE MARKET, FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION,

2020–2027 (USD MILLION) 63

TABLE 22 GLOBAL AUTOMATED CELL CULTURE MARKET, FOR CELL BANKS, BY REGION, 2020–2027 (USD MILLION) 64

TABLE 23 GLOBAL AUTOMATED CELL CULTURE MARKET, BY REGION, 2020–2027 (USD MILLION) 66

TABLE 24 AMERICAS: AUTOMATED CELL CULTURE MARKET, BY REGION, 2020–2027 (USD MILLION) 68

TABLE 25 AMERICAS: AUTOMATED CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION) 68

TABLE 26 AMERICAS: AUTOMATED CELL CULTURE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 68

TABLE 27 AMERICAS: AUTOMATED CELL CULTURE MARKET, FOR CONSUMABLES, BY TYPE, 2020–2027 (USD MILLION) 69

TABLE 28 AMERICAS: AUTOMATED CELL CULTURE MARKET, FOR VESSELS, BY TYPE, 2020–2027 (USD MILLION) 69

TABLE 29 AMERICAS: AUTOMATED CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 70

TABLE 30 AMERICAS: AUTOMATED CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION) 70

TABLE 31 NORTH AMERICA: AUTOMATED CELL CULTURE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 72

TABLE 32 NORTH AMERICA: AUTOMATED CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION) 72

TABLE 33 NORTH AMERICA: AUTOMATED CELL CULTURE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 72

TABLE 34 NORTH AMERICA: AUTOMATED CELL CULTURE MARKET, FOR CONSUMABLES, BY TYPE, 2020–2027 (USD MILLION) 73

TABLE 35 NORTH AMERICA: AUTOMATED CELL CULTURE MARKET, FOR VESSELS, BY TYPE, 2020–2027 (USD MILLION) 73

TABLE 36 NORTH AMERICA: AUTOMATED CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 74

TABLE 37 NORTH AMERICA: AUTOMATED CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION) 74

TABLE 38 US: AUTOMATED CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION) 75

TABLE 39 US: AUTOMATED CELL CULTURE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 75

TABLE 40 US: AUTOMATED CELL CULTURE MARKET, FOR CONSUMABLES, BY TYPE, 2020–2027 (USD MILLION) 76

TABLE 41 US: AUTOMATED CELL CULTURE MARKET, FOR VESSELS, BY TYPE, 2020–2027 (USD MILLION) 76

TABLE 42 US: AUTOMATED CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 77

TABLE 43 US: AUTOMATED CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION) 77

TABLE 44 CANADA: AUTOMATED CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION) 78

TABLE 45 CANADA: AUTOMATED CELL CULTURE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 78

TABLE 46 CANADA: AUTOMATED CELL CULTURE MARKET, FOR CONSUMABLES, BY TYPE, 2020–2027 (USD MILLION) 79

TABLE 47 CANADA: AUTOMATED CELL CULTURE MARKET, FOR VESSELS, BY TYPE, 2020–2027 (USD MILLION) 79

TABLE 48 CANADA: AUTOMATED CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 80

TABLE 49 CANADA: AUTOMATED CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION) 80

TABLE 50 LATIN AMERICA: AUTOMATED CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION) 81

TABLE 51 LATIN AMERICA: AUTOMATED CELL CULTURE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 81

TABLE 52 LATIN AMERICA: AUTOMATED CELL CULTURE MARKET, FOR CONSUMABLES, BY TYPE, 2020–2027 (USD MILLION) 82

TABLE 53 LATIN AMERICA: AUTOMATED CELL CULTURE MARKET, FOR VESSELS, BY TYPE, 2020–2027 (USD MILLION) 82

TABLE 54 LATIN AMERICA: AUTOMATED CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 83

TABLE 55 LATIN AMERICA: AUTOMATED CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION) 83

TABLE 56 EUROPE: AUTOMATED CELL CULTURE MARKET, BY REGION, 2020–2027 (USD MILLION) 85

TABLE 57 EUROPE: AUTOMATED CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION) 85

TABLE 58 EUROPE: AUTOMATED CELL CULTURE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 85

TABLE 59 EUROPE: AUTOMATED CELL CULTURE MARKET, FOR CONSUMABLES, BY TYPE, 2020–2027 (USD MILLION) 86

TABLE 60 EUROPE: AUTOMATED CELL CULTURE MARKET, FOR VESSELS, BY TYPE, 2020–2027 (USD MILLION) 86

TABLE 61 EUROPE: AUTOMATED CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 87

TABLE 62 EUROPE: AUTOMATED CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION) 87

TABLE 63 WESTERN EUROPE: AUTOMATED CELL CULTURE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 89

TABLE 64 WESTERN EUROPE: AUTOMATED CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION) 89

TABLE 65 WESTERN EUROPE: AUTOMATED CELL CULTURE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 90

TABLE 66 WESTERN EUROPE: AUTOMATED CELL CULTURE MARKET, FOR CONSUMABLES, BY TYPE, 2020–2027 (USD MILLION) 90

TABLE 67 WESTERN EUROPE: AUTOMATED CELL CULTURE MARKET, FOR VESSELS, BY TYPE, 2020–2027 (USD MILLION) 91

TABLE 68 WESTERN EUROPE: AUTOMATED CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 91

TABLE 69 WESTERN EUROPE: AUTOMATED CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION) 92

TABLE 70 GERMANY: AUTOMATED CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION) 92

TABLE 71 GERMANY: AUTOMATED CELL CULTURE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 93

TABLE 72 GERMANY: AUTOMATED CELL CULTURE MARKET, FOR CONSUMABLES, BY TYPE, 2020–2027 (USD MILLION) 93

TABLE 73 GERMANY: AUTOMATED CELL CULTURE MARKET, FOR VESSELS, BY TYPE, 2020–2027 (USD MILLION) 94

TABLE 74 GERMANY: AUTOMATED CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 94

TABLE 75 GERMANY: AUTOMATED CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION) 95

TABLE 76 FRANCE: AUTOMATED CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION) 95

TABLE 77 FRANCE: AUTOMATED CELL CULTURE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 96

TABLE 78 FRANCE: AUTOMATED CELL CULTURE MARKET, FOR CONSUMABLES, BY TYPE, 2020–2027 (USD MILLION) 96

TABLE 79 FRANCE: AUTOMATED CELL CULTURE MARKET, FOR VESSELS, BY TYPE, 2020–2027 (USD MILLION) 97

TABLE 80 FRANCE: AUTOMATED CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 97

TABLE 81 FRANCE: AUTOMATED CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION) 98

TABLE 82 UK: AUTOMATED CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION) 98

TABLE 83 UK: AUTOMATED CELL CULTURE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 99

TABLE 84 UK: AUTOMATED CELL CULTURE MARKET, FOR CONSUMABLES, BY TYPE, 2020–2027 (USD MILLION) 99

TABLE 85 UK: AUTOMATED CELL CULTURE MARKET, FOR VESSELS, BY TYPE, 2020–2027 (USD MILLION) 100

TABLE 86 UK: AUTOMATED CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 100

TABLE 87 UK: AUTOMATED CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION) 101

TABLE 88 ITALY: AUTOMATED CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION) 101

TABLE 89 ITALY: AUTOMATED CELL CULTURE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 102

TABLE 90 ITALY: AUTOMATED CELL CULTURE MARKET, FOR CONSUMABLES, BY TYPE, 2020–2027 (USD MILLION) 102

TABLE 91 ITALY: AUTOMATED CELL CULTURE MARKET, FOR VESSELS, BY TYPE, 2020–2027 (USD MILLION) 103

TABLE 92 ITALY: AUTOMATED CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 103

TABLE 93 ITALY: AUTOMATED CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION) 104

TABLE 94 SPAIN: AUTOMATED CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION) 104

TABLE 95 SPAIN: AUTOMATED CELL CULTURE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 105

TABLE 96 SPAIN: AUTOMATED CELL CULTURE MARKET, FOR CONSUMABLES, BY TYPE, 2020–2027 (USD MILLION) 105

TABLE 97 SPAIN: AUTOMATED CELL CULTURE MARKET, FOR VESSELS, BY TYPE, 2020–2027 (USD MILLION) 106

TABLE 98 SPAIN: AUTOMATED CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 106

TABLE 99 SPAIN: AUTOMATED CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION) 107

TABLE 100 REST OF WESTERN EUROPE: AUTOMATED CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION) 107

TABLE 101 REST OF WESTERN EUROPE: AUTOMATED CELL CULTURE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 108

TABLE 102 REST OF WESTERN EUROPE: AUTOMATED CELL CULTURE MARKET, FOR CONSUMABLES, BY TYPE, 2020–2027 (USD MILLION) 108

TABLE 103 REST OF WESTERN EUROPE: AUTOMATED CELL CULTURE MARKET, FOR VESSELS, BY TYPE, 2020–2027 (USD MILLION) 109

TABLE 104 REST OF WESTERN EUROPE: AUTOMATED CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 109

TABLE 105 REST OF WESTERN EUROPE: AUTOMATED CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION) 110

TABLE 106 EASTERN EUROPE: AUTOMATED CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION) 110

TABLE 107 EASTERN EUROPE: AUTOMATED CELL CULTURE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 111

TABLE 108 EASTERN EUROPE: AUTOMATED CELL CULTURE MARKET, FOR CONSUMABLES, BY TYPE, 2020–2027 (USD MILLION) 111

TABLE 109 EASTERN EUROPE: AUTOMATED CELL CULTURE MARKET, FOR VESSELS, BY TYPE, 2020–2027 (USD MILLION) 112

TABLE 110 EASTERN EUROPE: AUTOMATED CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 112

TABLE 111 EASTERN EUROPE: AUTOMATED CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION) 113

TABLE 112 ASIA-PACIFIC: AUTOMATED CELL CULTURE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 115

TABLE 113 ASIA-PACIFIC: AUTOMATED CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION) 116

TABLE 114 ASIA-PACIFIC: AUTOMATED CELL CULTURE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 116

TABLE 115 ASIA-PACIFIC: AUTOMATED CELL CULTURE MARKET, FOR CONSUMABLES, BY TYPE, 2020–2027 (USD MILLION) 117

TABLE 116 ASIA-PACIFIC: AUTOMATED CELL CULTURE MARKET, FOR VESSELS, BY TYPE, 2020–2027 (USD MILLION) 117

TABLE 117 ASIA-PACIFIC: AUTOMATED CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 118

TABLE 118 ASIA-PACIFIC: AUTOMATED CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION) 118

TABLE 119 JAPAN: AUTOMATED CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION) 119

TABLE 120 JAPAN: AUTOMATED CELL CULTURE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 119

TABLE 121 JAPAN: AUTOMATED CELL CULTURE MARKET, FOR CONSUMABLES, BY TYPE, 2020–2027 (USD MILLION) 120

TABLE 122 JAPAN: AUTOMATED CELL CULTURE MARKET, FOR VESSELS, BY TYPE, 2020–2027 (USD MILLION) 120

TABLE 123 JAPAN: AUTOMATED CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121

TABLE 124 JAPAN: AUTOMATED CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION) 121

TABLE 125 CHINA: AUTOMATED CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION) 122

TABLE 126 CHINA: AUTOMATED CELL CULTURE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 122

TABLE 127 CHINA: AUTOMATED CELL CULTURE MARKET, FOR CONSUMABLES, BY TYPE, 2020–2027 (USD MILLION) 123

TABLE 128 CHINA: AUTOMATED CELL CULTURE MARKET, FOR VESSELS, BY TYPE, 2020–2027 (USD MILLION) 123

TABLE 129 CHINA: AUTOMATED CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124

TABLE 130 CHINA: AUTOMATED CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION) 124

TABLE 131 INDIA: AUTOMATED CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION) 125

TABLE 132 INDIA: AUTOMATED CELL CULTURE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 125

TABLE 133 INDIA: AUTOMATED CELL CULTURE MARKET, FOR CONSUMABLES, BY TYPE, 2020–2027 (USD MILLION) 126

TABLE 134 INDIA: AUTOMATED CELL CULTURE MARKET, FOR VESSELS, BY TYPE, 2020–2027 (USD MILLION) 126

TABLE 135 INDIA: AUTOMATED CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 127

TABLE 136 INDIA: AUTOMATED CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION) 127

TABLE 137 AUSTRALIA: AUTOMATED CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION) 128

TABLE 138 AUSTRALIA: AUTOMATED CELL CULTURE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 128

TABLE 139 AUSTRALIA: AUTOMATED CELL CULTURE MARKET, FOR CONSUMABLES, BY TYPE, 2020–2027 (USD MILLION) 129

TABLE 140 AUSTRALIA: AUTOMATED CELL CULTURE MARKET, FOR VESSELS, BY TYPE, 2020–2027 (USD MILLION) 129

TABLE 141 AUSTRALIA: AUTOMATED CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 130

TABLE 142 AUSTRALIA: AUTOMATED CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION) 130

TABLE 143 SOUTH KOREA: AUTOMATED CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION) 131

TABLE 144 SOUTH KOREA: AUTOMATED CELL CULTURE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 131

TABLE 145 SOUTH KOREA: AUTOMATED CELL CULTURE MARKET, FOR CONSUMABLES, BY TYPE, 2020–2027 (USD MILLION) 132

TABLE 146 SOUTH KOREA: AUTOMATED CELL CULTURE MARKET, FOR VESSELS, BY TYPE, 2020–2027 (USD MILLION) 132

TABLE 147 SOUTH KOREA: AUTOMATED CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 133

TABLE 148 SOUTH KOREA: AUTOMATED CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION) 133

TABLE 149 REST OF ASIA-PACIFIC: AUTOMATED CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION) 134

TABLE 150 REST OF ASIA-PACIFIC: AUTOMATED CELL CULTURE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 134

TABLE 151 REST OF ASIA-PACIFIC: AUTOMATED CELL CULTURE MARKET, FOR CONSUMABLES, BY TYPE, 2020–2027 (USD MILLION) 135

TABLE 152 REST OF ASIA-PACIFIC: AUTOMATED CELL CULTURE MARKET, FOR VESSELS, BY TYPE, 2020–2027 (USD MILLION) 135

TABLE 153 REST OF ASIA-PACIFIC: AUTOMATED CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 136

TABLE 154 REST OF ASIA-PACIFIC: AUTOMATED CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION) 136

TABLE 155 MIDDLE EAST & AFRICA: AUTOMATED CELL CULTURE MARKET, BY REGION, 2020–2027 (USD MILLION) 138

TABLE 156 MIDDLE EAST & AFRICA: AUTOMATED CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION) 138

TABLE 157 MIDDLE EAST & AFRICA: AUTOMATED CELL CULTURE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 139

TABLE 158 MIDDLE EAST & AFRICA: AUTOMATED CELL CULTURE MARKET, FOR CONSUMABLES, BY TYPE, 2020–2027 (USD MILLION) 139

TABLE 159 MIDDLE EAST & AFRICA: AUTOMATED CELL CULTURE MARKET, FOR VESSELS, BY TYPE, 2020–2027 (USD MILLION) 140

TABLE 160 MIDDLE EAST & AFRICA: AUTOMATED CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 140

TABLE 161 MIDDLE EAST & AFRICA: AUTOMATED CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION) 141

TABLE 162 MIDDLE EAST: AUTOMATED CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION) 141

TABLE 163 MIDDLE EAST: AUTOMATED CELL CULTURE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 142

TABLE 164 MIDDLE EAST: AUTOMATED CELL CULTURE MARKET, FOR CONSUMABLES, BY TYPE, 2020–2027 (USD MILLION) 142

TABLE 165 MIDDLE EAST: AUTOMATED CELL CULTURE MARKET, FOR VESSELS, BY TYPE, 2020–2027 (USD MILLION) 143

TABLE 166 MIDDLE EAST: AUTOMATED CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 143

TABLE 167 MIDDLE EAST: AUTOMATED CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION) 144

TABLE 168 AFRICA: AUTOMATED CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION) 144

TABLE 169 AFRICA: AUTOMATED CELL CULTURE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 145

TABLE 170 AFRICA: AUTOMATED CELL CULTURE MARKET, FOR CONSUMABLES, BY TYPE, 2020–2027 (USD MILLION) 145

TABLE 171 AFRICA: AUTOMATED CELL CULTURE MARKET, FOR VESSELS, BY TYPE, 2020–2027 (USD MILLION) 146

TABLE 172 AFRICA: AUTOMATED CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 146

TABLE 173 AFRICA: AUTOMATED CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION) 147

TABLE 174 GLOBAL AUTOMATED CELL CULTURE MARKET, COMPANY RANKING ANALYSIS, 2020 148

TABLE 175 TOP PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE AUTOMATED CELL CULTURE MARKET 149

TABLE 176 PRODUCT APPROVALS/LAUNCHES 150

TABLE 177 ACQUISITIONS 151

TABLE 178 EXPANSIONS 151

TABLE 179 TECAN TRADING AG: PRODUCTS/SERVICES OFFERED 155

TABLE 180 TECAN TRADING AG: KEY DEVELOPMENTS 155

TABLE 181 SIEMENS: PRODUCTS OFFERED 158

TABLE 182 SIEMENS: KEY DEVELOPMENTS 158

TABLE 183 HITACHI, LTD: PRODUCTS/SERVICES OFFERED 161

TABLE 184 HITACHI, LTD: KEY DEVELOPMENTS 161

TABLE 185 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED 164

TABLE 186 THERMO FISHER SCIENTIFIC INC.: KEY DEVELOPMENTS 165

TABLE 187 SARTORIUS AG: PRODUCTS/SERVICES OFFERED 167

TABLE 188 SARTORIUS AG: KEY DEVELOPMENTS 167

TABLE 189 HAMILTON COMPANY: PRODUCTS/SERVICES OFFERED 169

TABLE 190 BECKMAN COULTER, INC.: PRODUCTS/SERVICES OFFERED 171

TABLE 191 F. HOFFMANN-LA ROCHE LTD: PRODUCTS/SERVICES OFFERED 174

TABLE 192 MERCK KGAA: PRODUCTS/SERVICES OFFERED 176

TABLE 193 BECTON, DICKINSON AND COMPANY: PRODUCTS/SERVICES OFFERED 180

TABLE 194 BECTON, DICKINSON AND COMPANY: KEY DEVELOPMENTS 180

15 LIST OF FIGURES

FIGURE 1 GLOBAL AUTOMATED CELL CULTURE MARKET STRUCTURE 20

FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES 26

FIGURE 3 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL AUTOMATED CELL CULTURE MARKET 29

FIGURE 4 DRIVER IMPACT ANALYSIS 31

FIGURE 5 RESTRAINT IMPACT ANALYSIS 32

FIGURE 6 PORTER’S FIVE FORCES ANALYSIS: GLOBAL AUTOMATED CELL CULTURE MARKET 34

FIGURE 7 VALUE CHAIN ANALYSIS OF THE AUTOMATED CELL CULTURE MARKET 36

FIGURE 8 GLOBAL AUTOMATED CELL CULTURE MARKET, BY TYPE, 2020 AND 2027 (USD MILLION) 41

FIGURE 9 GLOBAL AUTOMATED CELL CULTURE MARKET, BY PRODUCT, 2020 AND 2027 (USD MILLION) 45

FIGURE 10 GLOBAL AUTOMATED CELL CULTURE MARKET, BY APPLICATION, 2020 AND 2027 (USD MILLION) 50

FIGURE 11 GLOBAL AUTOMATED CELL CULTURE MARKET, BY END USER, 2020 AND 2027 (USD MILLION) 59

FIGURE 12 GLOBAL AUTOMATED CELL CULTURE MARKET, BY REGION, 2020 AND 2027 (USD MILLION) 65

FIGURE 13 AMERICAS: AUTOMATED CELL CULTURE MARKET SHARE, BY REGION, 2020 (%) 67

FIGURE 14 AMERICAS: AUTOMATED CELL CULTURE MARKET, BY REGION, 2020 AND 2027 (USD MILLION) 67

FIGURE 15 NORTH AMERICA: AUTOMATED CELL CULTURE MARKET SHARE, BY COUNTRY, 2020 (%) 71

FIGURE 16 NORTH AMERICA: AUTOMATED CELL CULTURE MARKET, BY COUNTRY, 2020 AND 2027 (USD MILLION) 71

FIGURE 17 EUROPE: AUTOMATED CELL CULTURE MARKET SHARE, BY REGION, 2020 (%) 84

FIGURE 18 EUROPE: AUTOMATED CELL CULTURE MARKET, BY REGION, 2020 AND 2027 (USD MILLION) 84

FIGURE 19 WESTERN EUROPE: AUTOMATED CELL CULTURE MARKET SHARE, BY COUNTRY, 2020 (%) 88

FIGURE 20 WESTERN EUROPE: AUTOMATED CELL CULTURE MARKET, BY COUNTRY, 2020 AND 2027 (USD MILLION) 88

FIGURE 21 ASIA-PACIFIC: AUTOMATED CELL CULTURE MARKET SHARE, BY COUNTRY, 2020 (%) 114

FIGURE 22 ASIA-PACIFIC: AUTOMATED CELL CULTURE MARKET, BY COUNTRY, 2020 AND 2027 (USD MILLION) 115

FIGURE 23 MIDDLE EAST & AFRICA: AUTOMATED CELL CULTURE MARKET SHARE, BY REGION, 2020 (%) 137

FIGURE 24 MIDDLE EAST & AFRICA: AUTOMATED CELL CULTURE MARKET, BY REGION, 2020 AND 2027 (USD MILLION) 137

FIGURE 25 BENCHMARKING OF MAJOR COMPETITORS 149

FIGURE 26 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL AUTOMATED CELL CULTURE MARKET 150

FIGURE 27 SALES & OPERATING INCOME MARGIN, 2020 152

FIGURE 28 RESEARCH & DEVELOPMENT EXPENDITURE, 2020 152

FIGURE 29 TECAN TRADING AG: FINANCIAL OVERVIEW SNAPSHOT 154

FIGURE 30 TECAN TRADING AG: SWOT ANALYSIS 156

FIGURE 31 SIEMENS: FINANCIAL OVERVIEW SNAPSHOT 157

FIGURE 32 SIEMENS: SWOT ANALYSIS 159

FIGURE 33 HITACHI, LTD: FINANCIAL OVERVIEW SNAPSHOT 160

FIGURE 34 HITACHI, LTD: SWOT ANALYSIS 162

FIGURE 35 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT 163

FIGURE 36 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS 165

FIGURE 37 SARTORIUS AG: FINANCIAL OVERVIEW SNAPSHOT 166

FIGURE 38 SARTORIUS AG: SWOT ANALYSIS 168

FIGURE 39 HAMILTON COMPANY: SWOT ANALYSIS 170

FIGURE 40 BECKMAN COULTER, INC: SWOT ANALYSIS 172

FIGURE 41 F. HOFFMANN-LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT 173

FIGURE 42 F. HOFFMANN-LA ROCHE LTD: SWOT ANALYSIS 174

FIGURE 43 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT 175

FIGURE 44 MERCK KGAA: SWOT ANALYSIS 177

FIGURE 45 BECTON, DICKINSON AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT 179

FIGURE 46 BECTON, DICKINSON AND COMPANY: SWOT ANALYSIS 181

Automated Cell Culture Market Segmentation


Automated Cell Culture Type Outlook (USD Billion, 2018-2030)



  • Whole Label Automation

  • Modular Automation


Automated Cell Culture Product Outlook (USD Billion, 2018-2030)



  • Vessels

  • Consumables


Automated Cell Culture Application Outlook (USD Billion, 2018-2030)



  • Diagnostic

  • Biopharmaceuticals production

  • Toxicity Test

  • Drug Screening and Development

  • Tissue Engineering and Regenerative Medicine

  • Stem Cell Research


Automated Cell Culture End User Outlook (USD Billion, 2018-2030)



  • Hospital and Diagnostic Laboratories

  • Pharmaceuticals and Biotechnology Companies

  • Cell Banks

  • Research Institutes


Automated Cell Culture Regional Outlook (USD Billion, 2018-2030)




  • North America Outlook (USD Billion, 2018-2030)


    • North America Automated Cell Culture by Type

      • Whole Label Automation

      • Modular Automation




    • North America Automated Cell Culture by Product

      • Vessels

      • Consumables




    • North America Automated Cell Culture by Application

      • Diagnostic

      • Biopharmaceuticals production

      • Toxicity Test

      • Drug Screening and Development

      • Tissue Engineering and Regenerative Medicine

      • Stem Cell Research




    • North America Automated Cell Culture by End User

      • Hospital and Diagnostic Laboratories

      • Pharmaceuticals and Biotechnology Companies

      • Cell Banks

      • Research Institutes




    • US Outlook (USD Billion, 2018-2030)


    • US Automated Cell Culture by Type

      • Whole Label Automation

      • Modular Automation




    • US Automated Cell Culture by Product

      • Vessels

      • Consumables




    • US Automated Cell Culture by Application

      • Diagnostic

      • Biopharmaceuticals production

      • Toxicity Test

      • Drug Screening and Development

      • Tissue Engineering and Regenerative Medicine

      • Stem Cell Research




    • US Automated Cell Culture by End User

      • Hospital and Diagnostic Laboratories

      • Pharmaceuticals and Biotechnology Companies

      • Cell Banks

      • Research Institutes




    • CANADA Outlook (USD Billion, 2018-2030)


    • CANADA Automated Cell Culture by Type

      • Whole Label Automation

      • Modular Automation

      • Posterior

      • Others




    • CANADA Automated Cell Culture by Product

      • Vessels

      • Consumables

      • Others




    • CANADA Automated Cell Culture by Application

      • Diagnostic

      • Biopharmaceuticals production

      • Toxicity Test

      • Drug Screening and Development

      • Tissue Engineering and Regenerative Medicine

      • Stem Cell Research




    • CANADA Automated Cell Culture by End User

      • Hospital and Diagnostic Laboratories

      • Pharmaceuticals and Biotechnology Companies

      • Cell Banks

      • Research Institutes





  • Europe Outlook (USD Billion, 2018-2030)






    • Europe Automated Cell Culture by Type

      • Whole Label Automation

      • Modular Automation




    • Europe Automated Cell Culture by Product

      • Vessels

      • Consumables




    • Europe Automated Cell Culture by Application

      • Diagnostic

      • Biopharmaceuticals production

      • Toxicity Test

      • Drug Screening and Development

      • Tissue Engineering and Regenerative Medicine

      • Stem Cell Research




    • Europe Automated Cell Culture by End User

      • Hospital and Diagnostic Laboratories

      • Pharmaceuticals and Biotechnology Companies

      • Cell Banks

      • Research Institutes



    • Germany Outlook (USD Billion, 2018-2030)


    • Germany Automated Cell Culture by Type

      • Whole Label Automation

      • Modular Automation




    • Germany Automated Cell Culture by Product

      • Vessels

      • Consumables




    • Germany Automated Cell Culture by Application

      • Diagnostic

      • Biopharmaceuticals production

      • Toxicity Test

      • Drug Screening and Development

      • Tissue Engineering and Regenerative Medicine

      • Stem Cell Research




    • Germany Automated Cell Culture by End User

      • Hospital and Diagnostic Laboratories

      • Pharmaceuticals and Biotechnology Companies

      • Cell Banks

      • Research Institutes



    • France Outlook (USD Billion, 2018-2030)


    • France Automated Cell Culture by Type

      • Whole Label Automation

      • Modular Automation




    • France Automated Cell Culture by Product

      • Vessels

      • Consumables




    • France Automated Cell Culture by Application

      • Diagnostic

      • Biopharmaceuticals production

      • Toxicity Test

      • Drug Screening and Development

      • Tissue Engineering and Regenerative Medicine

      • Stem Cell Research




    • France Automated Cell Culture by End User

      • Hospital and Diagnostic Laboratories

      • Pharmaceuticals and Biotechnology Companies

      • Cell Banks

      • Research Institutes




    • UK Outlook (USD Billion, 2018-2030)


    • UK Automated Cell Culture by Type

      • Whole Label Automation

      • Modular Automation




    • UK Automated Cell Culture by Product

      • Vessels

      • Consumables




    • UK Automated Cell Culture by Application

      • Diagnostic

      • Biopharmaceuticals production Toxicity Test

      • Drug Screening and Development

      • Tissue Engineering and Regenerative Medicine

      • Stem Cell Research




    • UK Automated Cell Culture by End User

      • Hospital and Diagnostic Laboratories

      • Pharmaceuticals and Biotechnology Companies

      • Cell Banks

      • Research Institutes




    • ITALY Outlook (USD Billion, 2018-2030)


    • ITALY Automated Cell Culture by Type

      • Whole Label Automation

      • Modular Automation




    • ITALY Automated Cell Culture by Product

      • Vessels

      • Consumables




    • ITALY Automated Cell Culture by Application

      • Diagnostic

      • Biopharmaceuticals production

      • Toxicity Test

      • Drug Screening and Development

      • Tissue Engineering and Regenerative Medicine

      • Stem Cell Research




    • ITALY Automated Cell Culture by End User

      • Hospital and Diagnostic Laboratories

      • Pharmaceuticals and Biotechnology Companies

      • Cell Banks

      • Research Institutes




    • SPAIN Outlook (USD Billion, 2018-2030)


    • Spain Automated Cell Culture by Type

      • Whole Label Automation

      • Modular Automation




    • Spain Automated Cell Culture by Product

      • Vessels

      • Consumables




    • Spain Automated Cell Culture by Application

      • Diagnostic

      • Biopharmaceuticals production

      • Toxicity Test

      • Drug Screening and Development

      • Tissue Engineering and Regenerative Medicine

      • Stem Cell Research




    • Spain Automated Cell Culture by End User

      • Hospital and Diagnostic Laboratories

      • Pharmaceuticals and Biotechnology Companies

      • Cell Banks

      • Research Institutes




    • Rest Of Europe Outlook (USD Billion, 2018-2030)


    • Rest Of Europe Automated Cell Culture by Type

      • Whole Label Automation

      • Modular Automation




    • REST OF EUROPE Automated Cell Culture by Product

      • Vessels

      • Consumables




    • REST OF EUROPE Automated Cell Culture by Application

      • Diagnostic

      • Biopharmaceuticals production

      • Toxicity Test

      • Drug Screening and Development

      • Tissue Engineering and Regenerative Medicine

      • Stem Cell Research




    • REST OF EUROPE Automated Cell Culture by End User

      • Hospital and Diagnostic Laboratories

      • Pharmaceuticals and Biotechnology Companies

      • Cell Banks

      • Research Institutes





  • Asia-Pacific Outlook (USD Billion, 2018-2030)






    • Asia-Pacific Automated Cell Culture by Type

      • Whole Label Automation

      • Modular Automation




    • Asia-Pacific Automated Cell Culture by Product

      • Vessels

      • Consumables




    • Asia-Pacific Automated Cell Culture by Application

      • Diagnostic

      • Biopharmaceuticals production

      • Toxicity Test

      • Drug Screening and Development

      • Tissue Engineering and Regenerative Medicine

      • Stem Cell Research




    • Asia-Pacific Automated Cell Culture by End User

      • Hospital and Diagnostic Laboratories

      • Pharmaceuticals and Biotechnology Companies

      • Cell Banks

      • Research Institutes




    • China Outlook (USD Billion, 2018-2030)


    • China Automated Cell Culture by Type

      • Whole Label Automation

      • Modular Automation




    • China Automated Cell Culture by Product

      • Vessels

      • Consumables




    • China Automated Cell Culture by Application

      • Diagnostic

      • Biopharmaceuticals production

      • Toxicity Test

      • Drug Screening and Development

      • Tissue Engineering and Regenerative Medicine

      • Stem Cell Research




    • China Automated Cell Culture by End User

      • Hospital and Diagnostic Laboratories

      • Pharmaceuticals and Biotechnology Companies

      • Cell Banks

      • Research Institutes




    • Japan Outlook (USD Billion, 2018-2030)


    • Japan Automated Cell Culture by Type

      • Whole Label Automation

      • Modular Automation




    • Japan Automated Cell Culture by Product

      • Vessels

      • Consumables




    • Japan Automated Cell Culture by Application

      • Diagnostic

      • Biopharmaceuticals production

      • Toxicity Test

      • Drug Screening and Development

      • Tissue Engineering and Regenerative Medicine

      • Stem Cell Research




    • Japan Automated Cell Culture by End User

      • Hospital and Diagnostic Laboratories

      • Pharmaceuticals and Biotechnology Companies

      • Cell Banks

      • Research Institutes




    • India Outlook (USD Billion, 2018-2030)


    • India Automated Cell Culture by Type

      • Whole Label Automation

      • Modular Automation




    • India Automated Cell Culture by Product

      • Vessels

      • Consumables




    • India Automated Cell Culture by Application

      • Diagnostic

      • Biopharmaceuticals production

      • Toxicity Test

      • Drug Screening and Development

      • Tissue Engineering and Regenerative Medicine

      • Stem Cell Research




    • India Automated Cell Culture by End User

      • Hospital and Diagnostic Laboratories

      • Pharmaceuticals and Biotechnology Companies

      • Cell Banks

      • Research Institutes




    • Australia Outlook (USD Billion, 2018-2030)


    • Australia Automated Cell Culture by Type

      • Whole Label Automation

      • Modular Automation




    • Australia Automated Cell Culture by Product

      • Vessels

      • Consumables




    • Australia Automated Cell Culture by Application

      • Diagnostic

      • Biopharmaceuticals production

      • Toxicity Test

      • Drug Screening and Development

      • Tissue Engineering and Regenerative Medicine

      • Stem Cell Research




    • Australia Automated Cell Culture by End User

      • Hospital and Diagnostic Laboratories

      • Pharmaceuticals and Biotechnology Companies

      • Cell Banks

      • Research Institutes




    • Rest of Asia-Pacific Outlook (USD Billion, 2018-2030)


    • Rest of Asia-Pacific Automated Cell Culture by Type

      • Whole Label Automation

      • Modular Automation




    • Rest of Asia-Pacific Automated Cell Culture by Product

      • Vessels

      • Consumables




    • Rest of Asia-Pacific Automated Cell Culture by Application

      • Diagnostic

      • Biopharmaceuticals production

      • Toxicity Test

      • Drug Screening and Development

      • Tissue Engineering and Regenerative Medicine

      • Stem Cell Research




    • Rest of Asia-Pacific Automated Cell Culture by End User

      • Hospital and Diagnostic Laboratories

      • Pharmaceuticals and Biotechnology Companies

      • Cell Banks

      • Research Institutes





  • Rest of the World Outlook (USD Billion, 2018-2030)






    • Rest of the World Automated Cell Culture by Type

      • Whole Label Automation

      • Modular Automation




    • Rest of the World Automated Cell Culture by Product

      • Vessels

      • Consumables




    • Rest of the World Automated Cell Culture by Application

      • Diagnostic

      • Biopharmaceuticals production

      • Toxicity Test

      • Drug Screening and Development

      • Tissue Engineering and Regenerative Medicine

      • Stem Cell Research




    • Rest of the World Automated Cell Culture by End User

      • Hospital and Diagnostic Laboratories

      • Pharmaceuticals and Biotechnology Companies

      • Cell Banks

      • Research Institutes




    • Middle East Outlook (USD Billion, 2018-2030)


    • Middle East Automated Cell Culture by Type

      • Whole Label Automation

      • Modular Automation




    • Middle East Automated Cell Culture by Product

      • Vessels

      • Consumables




    • Middle East Automated Cell Culture by Application

      • Diagnostic

      • Biopharmaceuticals production

      • Toxicity Test

      • Drug Screening and Development

      • Tissue Engineering and Regenerative Medicine

      • Stem Cell Research




    • Middle East Automated Cell Culture by End User

      • Hospital and Diagnostic Laboratories

      • Pharmaceuticals and Biotechnology Companies

      • Cell Banks

      • Research Institutes




    • Africa Outlook (USD Billion, 2018-2030)


    • Africa Automated Cell Culture by Type

      • Whole Label Automation

      • Modular Automation




    • Africa Automated Cell Culture by Product

      • Vessels

      • Consumables



    • Africa Automated Cell Culture by Application









      • Diagnostic

      • Biopharmaceuticals production

      • Toxicity Test

      • Drug Screening and Development

      • Tissue Engineering and Regenerative Medicine

      • Stem Cell Research




    • Africa Automated Cell Culture by End User

      • Hospital and Diagnostic Laboratories

      • Pharmaceuticals and Biotechnology Companies

      • Cell Banks

      • Research Institutes




    • Latin America Outlook (USD Billion, 2018-2030)


    • Latin America Automated Cell Culture by Type

      • Whole Label Automation

      • Modular Automation




    • Latin America Automated Cell Culture by Product

      • Vessels

      • Consumables




    • Latin America Automated Cell Culture by Application

      • Diagnostic

      • Biopharmaceuticals production

      • Toxicity Test

      • Drug Screening and Development

      • Tissue Engineering and Regenerative Medicine

      • Stem Cell Research




    • Latin America Automated Cell Culture by End User

      • Hospital and Diagnostic Laboratories

      • Pharmaceuticals and Biotechnology Companies

      • Cell Banks

      • Research Institutes





Leading companies partner with us for data-driven Insights.
Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response
Invalid